It has been proposed that acridine might be an MT drug against AD, acting on AChE, BuChE, dual specificity tyrosine kinase 1A (Dyrk 1A), Aβ, and prion protein (PrPC) [111]. The gene discussed is ACHE; the disease is Alzheimer disease.